nach oben

Cardiovascular Toxicology

Erschienen in:

11.03.2024 | Research

Association Between Cancer and Cardiovascular Toxicity: A Nationwide Cross-Sectional Study on NHANES 1999–2018

verfasst von: Ruihuan Shen, Tong Zou

Erschienen in: Cardiovascular Toxicology | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

There is a dearth of evidence pertaining to the relationship of cardiovascular disease (CVD) and its subtype with adjudicated cancer, thereby limiting our understanding of the heightened risk of CVD resulting from long-term complications of cancer and its therapies. The aim of this study was to quantify the risks of CVD and its subtypes in adult cancer survivors compared with cancer-free controls in a nationwide cross-sectional study on Continuous National Health and Nutrition Examination Survey (NHANES). We included 44,442 participants ranging in age from 20 to 85 years. Cancer and CVD diagnoses were ascertained via the household questionnaires. The association of cancer status with the risk of CVD and CVD subtype was examined using weighted logistic regression. Stratification analyses were also performed by age, sex, race, marital status, income status, educational level, and hyperlipidemia. The Wald test was used to calculate P-value for interaction. A total of 4178 participants have cancer, while 4829 participants had CVD, respectively. In the multivariable-adjusted model, the cancer was consistently linked to an elevated risk of CVD. Stratification analyses showed that stronger association between cancer status and CVD risk was found in younger adults, non-white, and participants living without a spouse or partner, and without hyperlipidemia. Our study confirmed that cancer participants were strongly linked to living with CVD, independent of traditional cardiovascular risk factors, especially in younger adults, non-white, and participants living without a spouse or partner, and without hyperlipidemia. There exists a pressing requirement to establish effective strategies for the prevention of CVD within this population characterized by a heightened risk.

Nur mit Berechtigung zugänglich

Stoltzfus, K. C., Zhang, Y., Sturgeon, K., Sinoway, L. I., Trifiletti, D. M., Chinchilli, V. M., & Zaorsky, N. G. (2020). Fatal heart disease among cancer patients. Nature Communications, 11(1), 2011.PubMedPubMedCentralCrossRef

Sturgeon, K. M., Deng, L., Bluethmann, S. M., Zhou, S., Trifiletti, D. M., Jiang, C., Kelly, S. P., & Zaorsky, N. G. (2019). A population-based study of cardiovascular disease mortality risk in US cancer patients. European Heart Journal, 40(48), 3889–3897.PubMedPubMedCentralCrossRef

Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Robin Yabroff, K., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019). Cancer treatment and survivorship statistics. CA: A Cancer Journal for Clinicians, 69(5), 363–385.PubMed

Karlstaedt, A., Moslehi, J., & de Boer, R. A. (2022). Cardio-onco-metabolism: Metabolic remodelling in cardiovascular disease and cancer. Nature Reviews Cardiology, 19(6), 414–425.PubMedPubMedCentralCrossRef

Sener, U., & Keser, Z. (2022). Ischemic stroke in patients with malignancy. Mayo Clinic Proceedings, 97(11), 2139–2144.PubMedCrossRef

Hahn, V. S., Zhang, K. W., Sun, L., Narayan, V., Lenihan, D. J., & Ky, B. (2021). Heart failure with targeted cancer therapies: Mechanisms and cardioprotection. Circulation Research, 128(10), 1576–1593.PubMedPubMedCentralCrossRef

Makker, V., Colombo, N., Herráez, A. C., Santin, A. D., Colomba, E., Miller, D. S., Fujiwara, K., Pignata, S., Baron-Hay, S., Ray-Coquard, I., Shapira-Frommer, R., Ushijima, K., Sakata, J., Yonemori, K., Kim, Y. M., Guerra, E. M., Sanli, U. A., McCormack, M. M., Smith, A. D., … Lorusso, D. (2022). Lenvatinib plus pembrolizumab for advanced endometrial cancer. New England Journal of Medicine, 386(5), 437–448.PubMedCrossRef

Schoormans, D., Vissers, P. A. J., van Herk-Sukel, M. P. P., Denollet, J., Pedersen, S. S., Dalton, S. O., Rottmann, N., & van de Poll-Franse, L. (2018). Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors. Cancer Medicine, 7(10), 4952–4963.PubMedPubMedCentralCrossRef

Wang, L., Wang, F., Chen, L., Geng, Y., Shulin, Y., & Chen, Z. (2021). Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: An American population-based cohort study. European Heart Journal, 42(1), 101–109.PubMedCrossRef

10.

Shin, J., Ko, H., Choi, Y. H., Choi, I., & Song, Y. M. (2019). Risk of comorbid cardiovascular disease in Korean long-term cancer survivors. European Journal of Cancer Care (Engl), 28(6), e13151.CrossRef

11.

About the National Health and Nutrition Examination Survey. National Center for Health Statistics; 2020. Retrieved from https://www.cdc.gov/nchs/about/index.htm

12.

Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Methods and Analytic Guidelines. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2020. Retrieved from: https://www.cdc.gov/nchs/ahcd/survey_methods.htm

13.

Cowan, A. E., Jun, S., Gahche, J. J., Tooze, J. A., Dwyer, J. T., Eicher-Miller, H. A., Bhadra, A., Guenther, P. M., Potischman, N., Dodd, K. W., & Bailey, R. L. (2018). Dietary supplement use differs by socioeconomic and health-related characteristics among US adults, NHANES 2011–2014. Nutrients, 10(8), 1114.PubMedPubMedCentralCrossRef

14.

Ogden, C. L., Carroll, M. D., Fakhouri, T. H., Hales, C. M., Fryar, C. D., Li, X., & Freedman, D. S. (2018). Prevalence of obesity among youths by household income and education level of head of household—United States 2011–2014. MMWR Morbidity and Mortality Weekly Report, 67(6), 186–189.PubMedPubMedCentralCrossRef

15.

Defining Adult Overweight and Obesity. Centers of Disease Control and prevention. Overweight & Obesity; 2021. Retrieved from https://www.cdc.gov/obesity/basics/adult-defining.html

16.

Kammerlander, A. A., Mayrhofer, T., Ferencik, M., Pagidipati, N. J., Karady, J., Ginsburg, G. S., Lu, M. T., Bittner, D. O., Puchner, S. B., Bihlmeyer, N. A., Meyersohn, N. M., Emami, H., Shah, S. H., Douglas, P. S., & Hoffmann, U. (2021). Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care, 44(4), 1038–1045.PubMedPubMedCentralCrossRef

17.

van’t Klooster, C. C., Ridker, P. M., Cook, N. R., Aerts, J. G. J. V., Westerink, J., Asselbergs, F. W., van der Graaf, Y., Visseren, F. L. J., Asselbergs, F. W., Nathoe, H. M., de Borst, G. J., Bots, M. L., Geerlings, M. I., Emmelot, M. H., de Jong, P. A., Leiner, T., Lely, A. T., van der Kaaij, N. P., Kappelle, L. J., … Westerink, J. (2020). Prediction of lifetime and 10-year risk of cancer in individual patients with established cardiovascular disease. JACC: CardioOncology, 2(3), 400–410.

18.

Panagiotakos, D., Chrysohoou, C., Damigou, E., Barkas, F., Liberopoulos, E., Tsioufis, C., Sfikakis, P. P., & Pitsavos, C. (2023). Prediction of lifetime risk for cardiovascular disease, by risk factors level: The ATTICA epidemiological cohort study (2002–2022). Annals of Epidemiology, 87, 17–24.PubMedCrossRef

19.

Haider, A., Bengs, S., Luu, J., Osto, E., Siller-Matula, J. M., Muka, T., & Gebhard, C. (2020). Sex and gender in cardiovascular medicine: Presentation and outcomes of acute coronary syndrome. European Heart Journal, 41(13), 1328–1336.PubMedCrossRef

20.

Kirschbaum, T. K., Sudharsanan, N., Manne-Goehler, J., De Neve, J. W., Lemp, J. M., Theilmann, M., Marcus, M. E., Ebert, C., Chen, S., Yoosefi, M., & Sibai, A. M. (2020). The association of socioeconomic status with hypertension in 76 low-and middle-income countries. Journal of the American College of Cardiology, 80(8), 804–817.CrossRef

21.

Mefford, M. T., Li, B. H., Qian, L., Reading, S. R., Harrison, T. N., Scott, R. D., Cavendish, J. J., Jacobsen, S. J., Kanter, M. H., Woodward, M., & Reynolds, K. (2020). Sex-specific trends in acute myocardial infarction within an integrated healthcare network, 2000 through 2014. Circulation, 141(7), 509–519.PubMedCrossRef

22.

Wong, C. W., Kwok, C. S., Narain, A., Gulati, M., Mihalidou, A. S., Pensee, W., Alasnag, M., Myint, P. K., & Mamas, M. A. (2018). Marital status and risk of cardiovascular diseases: a systematic review and meta-analysis. Heart, 104(23), 1937–1948.PubMedCrossRef

23.

Dhindsa, D. S., Khambhati, J., Schultz, W. M., Tahhan, A. S., & Quyyumi, A. A. (2020). Marital status and outcomes in patients with cardiovascular disease. Trends in Cardiovascular Medicine, 30(4), 215–220.PubMedCrossRef

24.

Yang, K., Zhang, Y., Saito, E., Rahman, M. S., Gupta, P. C., Sawada, N., Tamakoshi, A., Gao, Y. T., Koh, W. P., Shu, X. O., & Tsuji, I. (2019). Association between educational level and total and cause-specific mortality: a pooled analysis of over 694 000 individuals in the Asia Cohort Consortium. British Medical Journal Open, 9(8), e026225.

25.

Hasbani, N. R., Ligthart, S., Brown, M. R., Heath, A. S., Bebo, A., Ashley, K. E., Boerwinkle, E., Morrison, A. C., Folsom, A. R., Aguilar, D., & de Vries, P. S. (2022). American heart association’s life’s simple 7: Lifestyle recommendations, polygenic risk, and lifetime risk of coronary heart disease. Circulation, 145(11), 808–818.PubMedPubMedCentralCrossRef

26.

Krishnappa, D., Wang, W., Rooney, M. R., Norby, F. L., Oldenburg, N. C., Soliman, E. Z., Alonso, A., Jin, O., Dudley, S. C., Jr., Lutsey, P. L., & Chen, L. Y. (2021). Life’s Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study. International Journal of Cardiology, 332, 70–77.PubMedCrossRef

27.

Shen, R., Zhao, N., Wang, J., Guo, P., Shen, S., Liu, D., Liu, D., & Zou, T. (2022). Association between socioeconomic status and arteriosclerotic cardiovascular disease risk and cause-specific and all-cause mortality: Data from the 2005–2018 National Health and Nutrition Examination Survey. Frontiers in Public Health, 10, 1017271.PubMedPubMedCentralCrossRef

28.

Kaneko, H., Suzuki, Y., Ueno, K., Okada, A., Fujiu, K., Matsuoka, S., Michihata, N., Jo, T., Takeda, N., Morita, H., & Kamiya, K. (2022). Association of life’s simple 7 with incident cardiovascular disease in 53 974 patients with cancer. European Journal of Preventive Cardiology, 29(18), 2324–2332.PubMedCrossRef

29.

Johnson, C. L., Paulose-Ram, R., Ogden, C. L., Carroll, M. D., Kruszan-Moran, D., Dohrmann, S. M., & Curtin, L. R. (2013). National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Statistics, 2(161), 1–24.

30.

Chen, T. C., Clark, J., Riddles, M. K., Mohadjer, L. K., & Fakhouri, T. H. (2020). National health and nutrition examination survey, 2015–2018: sample design and estimation procedures. Vital Health Statistics, 2(184), 1–35.

31.

Moriarity, C., Parsons, V. L., Jonas, K., Schar, B. G., Bose, J., & Bramlett, M. D. (2022). Sample design and estimation structures for the national health interview survey, 2016–2025. Vital Health Statistics, 1(191), 1–30.

32.

Yeh, E. T., & Bickford, C. L. (2009). Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management. Journal of the American College of Cardiology, 53(24), 2231–2247.PubMedCrossRef

33.

Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022). Management of common clinical problems experienced by survivors of cancer. Lancet, 399(10334), 1537–1550.PubMedCrossRef

34.

Accordino, M. K., Neugut, A. I., & Hershman, D. L. (2014). Cardiac effects of anticancer therapy in the elderly. Journal of Clinical Oncology, 32(24), 2654–2661.PubMedPubMedCentralCrossRef

35.

Brandão, S. R., Carvalho, F., Amado, F., Ferreira, R., & Costa, V. M. (2022). Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings. Metabolism, 134, 155250.PubMedCrossRef

36.

Magdy, T., Jouni, M., Kuo, H. H., Weddle, C. J., Lyra-Leite, D., Fonoudi, H., Romero-Tejeda, M., Gharib, M., Javed, H., Fajardo, G., Ross, C. J. D., Carleton, B. C., Bernstein, D., & Burridge, P. W. (2022). Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity. Circulation, 145(4), 279–294.PubMedCrossRef

37.

Matthews, A. A., Hinton, S. P., Stanway, S., Lyon, A. R., Smeeth, L., Bhaskaran, K., & Lund, J. L. (2021). Risk of cardiovascular diseases among older breast cancer survivors in the United States: A matched cohort study. Journal of the National Comprehensive Cancer Network, 19(3), 275–284.PubMedCrossRef

38.

Hamood, R., Hamood, H., Merhasin, I., & Keinan-Boker, L. (2019). Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study. Journal of Cardiology, 73(4), 280–291.PubMedCrossRef

39.

Chang, J. S., Shin, J., Park, E. C., & Kim, Y. B. (2019). Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors. Breast, 43, 48–54.PubMedCrossRef

40.

Lee, S. F., Yip, P. L., Vellayappan, B. A., Chee, C. E., Wong, L. C., Wan, E. Y. F., Chan, E. W. Y., Lee, C. F., Lee, F. A. S., & Luque-Fernandez, M. A. (2022). Incident cardiovascular diseases among survivors of high-risk stage II-III colorectal cancer: A cluster-wide cohort study. Journal of the National Comprehensive Cancer Network, 20(10), 1125–1133.PubMedCrossRef

41.

Kenzik, K. M., Balentine, C., Richman, J., Kilgore, M., Bhatia, S., & Williams, G. R. (2018). New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer. Journal of Clinical Oncology, 36(6), 609–616.PubMedCrossRef

42.

Wang, C. Y., Zoungas, S., Voskoboynik, M., & Mar, V. (2022). Cardiovascular disease and malignant melanoma. Melanoma Research, 32(3), 135–141.PubMedCrossRef

43.

Strongman, H., Gadd, S., Matthews, A., Mansfield, K. E., Stanway, S., Lyon, A. R., dos-Santos-Silva, I., Smeeth, L., & Bhaskaran, K. (2019). Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet, 394(10203), 1041–1054.PubMedPubMedCentralCrossRef

44.

Armenian, S. H., Lanfang, X., Ky, B., Sun, C., Farol, L. T., Pal, S. K., Douglas, P. S., Bhatia, S., & Chao, C. (2016). Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study. Journal of Clinical Oncology, 34(10), 1122–1130.PubMedPubMedCentralCrossRef

45.

Andersson, A., Melin, B., Enblad, G., Erlanson, M., Johansson, A. S., Molin, D., Tavelin, B., & Näslund, U. (2021). High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma—is there a need for intervention in long-term survivors? Upsala Journal of Medical Sciences. https://doi.org/10.48101/ujms.v126.6117CrossRefPubMedPubMedCentral

46.

de Vries, S., Haaksma, M. L., Jóźwiak, K., Schaapveld, M., Hodgson, D. C., Lugtenburg, P. J., Krol, A. D. G., Petersen, E. J., Johan, D., van Spronsen, S., Ahmed, M. H., Aleman, B. M. P., & van Leeuwen, F. E. (2023). Development and validation of risk prediction models for coronary heart disease and heart failure after treatment for Hodgkin lymphoma. Journal of Clinical Oncology, 41(1), 86–95.PubMedCrossRef

47.

Yoon, D. W., Shin, D. W., Cho, J. H., Yang, J. H., Jeong, S. M., Han, K., & Park, S. H. (2019). Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients. Lung Cancer, 136, 115–121.PubMedCrossRef

48.

Florido, R., Daya, N. R., Ndumele, C. E., Koton, S., Russell, S. D., Prizment, A., Blumenthal, R. S., Matsushita, K., Mok, Y., Felix, A. S., Coresh, J., Joshu, C. E., Platz, E. A., & Selvin, E. (2022). Cardiovascular disease risk among cancer survivors: The atherosclerosis risk in communities (ARIC) study. Journal of the American College of Cardiology, 80(1), 22–32.PubMedPubMedCentralCrossRef

49.

Kim, K. J., Song, J. E., Kim, J. Y., Bae, J. H., Kim, N. H., Yoo, H. J., Kim, H. Y., Seo, J. A., Kim, N. H., Lee, J., Choi, K. M., Baik, S. H., & Kim, S. G. (2020). Effects of radioactive iodine treatment on cardiovascular disease in thyroid cancer patients: A nationwide cohort study. Annals of Translational Medicine, 8(19), 1235.PubMedPubMedCentralCrossRef

50.

Lega, I. C., & Lipscombe, L. L. (2020). Review: Diabetes, obesity, and cancer-pathophysiology and clinical implications. Endocrine Reviews, 41(1), bnz014.PubMedCrossRef

51.

Michel, L., Schadendorf, D., & Rassaf, T. (2020). Oncocardiology: New challenges, new opportunities. Onkokardiologie: Neue Herausforderungen, neue Möglichkeiten. Herz, 45(7), 619–625.PubMedPubMedCentralCrossRef

52.

Khan, S. S., & Greenland, P. (2020). Comprehensive cardiovascular health promotion for successful prevention of cardiovascular disease. JAMA, 324(20), 2036–2037.PubMedCrossRef

53.

Yang, Q., Cogswell, M. E., Dana Flanders, W., Hong, Y., Zhang, Z., Loustalot, F., Gillespie, C., Merritt, R., & Frank, BHu. (2012). Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA, 307(12), 1273–1283.PubMedPubMedCentralCrossRef

54.

Gaye, B. \, Canonico, M., Perier, M. C., Samieri, C., Berr, C., Dartigues, J.-F., Tzourio, C., Elbaz, A., & Empana, J. P. (2017). Ideal cardiovascular health, mortality, and vascular events in elderly subjects: The three-city study. Journal of the American College of Cardiology, 69(25), 3015–3026.PubMedCrossRef

55.

Perak, A. M., Ning, H., Khan, S. S., Bundy, J. D., Allen, N. B., Lewis, C. E., Jacobs, D. R., Van Horn, L. V., & Lloyd-Jones, D. M. (2020). Associations of late adolescent or young adult cardiovascular health with premature cardiovascular disease and mortality. Journal of the American College of Cardiology, 76(23), 2695–2707.PubMedPubMedCentralCrossRef

56.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Donald Lloyd-Jones, J., McEvoy, W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B. (2019). ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology., 74(10), 1376–1414.PubMedPubMedCentralCrossRef

57.

Walker, W. H., II., Meléndez-Fernández, O. H., Pascoe, J. L., Zhang, N., & DeVries, A. C. (2020). Social enrichment attenuates chemotherapy induced pro-inflammatory cytokine production and affective behavior via oxytocin signaling. Brain, Behavior, and Immunity, 89, 451–464.PubMedPubMedCentralCrossRef

Titel: Association Between Cancer and Cardiovascular Toxicity: A Nationwide Cross-Sectional Study on NHANES 1999–2018
verfasst von: Ruihuan Shen
Tong Zou
Publikationsdatum: 11.03.2024
Verlag: Springer US
Erschienen in: Cardiovascular Toxicology / Ausgabe 4/2024
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-024-09845-6

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2024

The Association of Iron Intake and Hypertension, Does Iron Intake Decrease Blood Pressure?

Correlation Between Blood Cadmium Levels and Platelet Characteristics, As Well As Their Impact on Susceptibility to Coronary Heart Disease: Findings from NHANES 2005–2018 Data

Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients

Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer

Effects of Halloysite Nanotubes and Multi-walled Carbon Nanotubes on Kruppel-like Factor 15-Mediated Downstream Events in Mouse Hearts After Intravenous Injection

Subacute Exposure to Gaseous Pollutants from Diesel Engine Exhaust Attenuates Capsaicin-Induced Cardio-Pulmonary Reflex Responses Involving Oxidant Stress Mechanisms in Adult Wistar Rats